Orthotopic heart transplantation in patients with univentricular physiology

Current Cardiology Reviews

Volumn 7, Issue 2, 2011, Pages 85-91

  Michielon, Guido ^a   Carotti, Adriano ^a   Pongiglione, Giacomo ^a   Cogo, Paola ^a   Parisi, Francesco ^a  

^a Dipartimento Medico Chirurgico di Cardiologia Pediatrica   (Italy)

Author keywords

Fontan failure; Pediatric heart transplantation; Univertricular physiology

Indexed keywords

CONGENITAL HEART DISEASE; FONTAN PROCEDURE; HEART FAILURE; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HUMAN; PALLIATIVE THERAPY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT FAILURE;

CHILD; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 80054121899     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/157340311797484259     Document Type: Review

References (55)

1. Morris CD, Menashe VD. 25-year mortality after surgical repair of congenital heart defects in childhood. J Am Med Assoc 1991; 266: 3447-52.
2. Giannico S, Hammad F, Amodeo A, Michielon G, et al. Clinical outcome of 193 extracardiac Fontan patients: the first 15 years. J Am Coll Cardiol 2006; 10: 2065-73.
3. Hasaniya NW, Razzouk AJ, Bailey LL, et al. In situ pericardial extracardiac lateral tunnel Fontan operation: fifteen year experience. J Thorac Cardiovasc Surg 2010; 140: 1076-83.
4. Kim SJ, Kim WH, Lim HG, et al. Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg 2008; 136: 108-116.
5. Driscoll DJ. Long-term results of the Fontan operation. Pediatr Cardiol 2007; 28: 438-442.
6. Tweddel JS, Nersesian M, Mussatto KA, et al. Fontan palliation in the modern era: factors impacting mortality and morbidity. Ann Thorac Surg 2009; 88: 1291-1299.
7. Yeh TJR, Williams WG, Mc Crindle BW, et al. Equivalent survival following cavopulmonary shunt with or without the Fontan procedure. Eur J Cardiothorac Surg 1999; 16: 111-116.
8. Carey JA, Hamilton LJR, Hilton CJ, et al. Orthotopic heart transplantation for the failing Fontan circulation. Eur J Cardiothorac Surg. 1998; 14: 7-14.
9. Gamba A, Merlo M, Fiocchi R, et al. Heart transplantation in patients with previous Fontan operations. J Thorac Cardiovasc Surg 2004; 127: 555-62.
10. Michielon G Parisi F, Squitieri C, et al. Orthotopic heart transplantation for congenital heart disease: an alternative for high-risk Fontan candidates? Circulation 2003; 108 II: 140-149.
11. Kirk R, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirteen official pediatric heart transplantation report-2010. J Heart Lung Tranplant 2010; 29: 1119-1128.
12. Michielon G, Parisi F, DiCarlo D, et al. Orthotopic heart transplantation for failing single ventricle physiology. Eur J Cardiothorac Surg 2003; 24: 502-510.
13. Norwood WI, Jacobs ML. Fontan's procedure in two stages. Am J Surg 1993; 166: 548-51.
14. Diller GP, Giardini A, Dimopoulos K, Hager A. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J 2010.
15. Khairy P, Fernandes SM, Mayer JE, et al. Long term survival, modes of death and predictors of mortality in patients with Fontan surgery. 2008;117: 85-92.
16. Bailey LL, Gundry SR, Razzouk AJ, et al. Bless the babies: onehundred fifteen late survivors of heart transplantation during the first year of life. J Thorac Cardiovasc Surg 1993; 105: 805-15.
17. Fontan F, Kirklin JW, Fernandez G. Outcome after a perfect Fontan operation. Circulation 1990; 81: 1520-36.
18. Silvilairat S, Cabalka AK, Cetta F, Hagler DJ, et al. Protein-losing enteropathy after the Fontan operation: associations and predictors of clinical outcome. Congenit Heart Dis 2008; 3: 262-268.
19. Zahorec M, Kovacikova L Martanovic P, et al. The use of highfrequency jet ventilation for removal of obstructing casts in patients with plastic bronchitis. Pediatr Crit Care Med 2009; 10: e34-6.
20. Beghetti M. Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies. Heart 2010; 96: 911-916.
21. Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR, et al. Cardiac transplantation after the Fontan or Glenn procedure; J Am Coll Cardiol 2004; 44: 2065-2072.
22. Mitchell MB, Campbell DN, Boucek MM. Heart transplantation for the failing Fontan circulation. Sem Thorac Cardiovasc Surgery 2004; 7: 56-64.
23. Hosein RBM, Clarke AJB, McGuirk SP, Brawn WJ, et al. Factors influencing early and late outcome following the Fontan procedure in the current era. The "two commandments"?. Eur J Cardiothorac Surg 2007; 31: 344-353.
24. Penny DJ, Rigby ML, Redington AN. Abnormal patterns of intraventricular flow and diastolic filling after the Fontan operation: evidence for incoordinate ventricular wall motion. Br Heart J1991; 66: 375-378.
25. Cheung YF, Penny DJ, Redington AN. Serial assessment of left ventricular diastolic function after Fontan procedure. Heart 2000; 83: 420-424.
26. Culbertson CB, George BL, Day RW. Factors influencing survival of patients with heterotaxy syndrome undergoing the Fontan procedure. J Am Coll Cardiol 1992; 20: 678-84.
27. Bartz PJ, Driscoll DJ, Dereani JA, et al. Early and late results of the modified Fontan operation for heterotaxy syndrome. J Am Coll Cardiol 2006; 48: 2301-2305.
28. Petko M, Myung RJ, Wernovsky G, et al. Surgical reinterventions following the Fontan procedure. Eur J Cardiothorac Surg 2003; 24: 255-59.
29. Mavroudis C, Backer CL, Deal BJ, et al. Total cavopulmonary conversion and Maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg 2001; 122: 863-71.
30. Kussmaul WG, Noordergraaf A, Laskey WK, et al. Right ventricular- pulmonary arterial interactions. Ann Biomed Eng 1992; 20: 63-80.
31. West JB, Dollery CT, Naimark A. Distribution of blood flow in isolated lungs: relation to vascular and alveolar pressures. J Appl Physiol 1964; 19: 713-724.
32. Humbert M, Sitbon O, Simmoneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351; 1425-36.
33. Levy M, Danel C, Laval AM, et al. Nitric oxide synthase expression by pulmonary arteries: a predictive marker of Fontan procedure outcome? J Thorac Cardiovasc Surg 2003; 125: 1083-90.
34. Kirshbom PM, Mahle WT, Joyner RW, et al. The endothelin-1 G5665T polymorphism impacts transplant free survival for single ventricle patients. J Thorac Cardiovasc Surg 2008; 136: 117-122.
35. Ostrow AM, Freeze H, Rychik J. Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 2006; 82: 695-701.
36. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis 2007; 2: 288-300.
37. Lenz D, Hambsch J, Schneider P, et al. Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection? Critical Care 2003; 7: 185-190.
38. Goldberg DJ, Dodds K, Rychik J. Rare problems associated with the Fontan circulation. Cardiol Young 2010; 20: 113-119.
39. Rychik J, Spray TL. Strategies to treat protein-losing enteropathy. Sem Thorac Cardiovasc Surg pediatr Card Surg Annu 2002; 5: 3-11.
40. Wilson J, Russel J, Williams W. Fenestration of the Fontan circuit as treatment for plastic bronchitis. Pediatr Cardiol 2005; 26: 717-719.
41. Do TB, Chu JM, Berdjis, et al. Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case report and review of the literature. Pediatr Cardiol 2009; 30: 352-355.
42. Reinhardt Z, Uzun O, Bhole V, et al. Sildenafil in the management of the failing Fontan circulation. Cardiol Young 2010; 20: 522-525.
43. Uzun O, Wong JK, Bhole V. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. Ann Thorac Surg 2006; 82: e39-40.
44. Apostolopoulou SC, Papagiannis J, Rammos S. Bosentan induces clinical and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation. J Heart Lung Transplant 2005; 24: 1174-6.
45. Ghanayem NS, Berger S, Tweddell JS. Medical management of the failing Fontan. Pediatr Cardiol 2007; 28: 465-471.
46. Bernstein D, Naftel D, Chin C, et al. Outcome of listing for cardiac transplantation for failed Fontan. A multi-institutional study. Circulation 2006; 114: 273-280.
47. Lamour JM, Kanter KR, Naftel DC, et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol 2009; 54: 160-165.
48. Simmonds J, Burch M, Dawkins H, Tsang V. Heart transplantation after congenital heart surgery: improving results and future goals. Eur J Cardiothorac Surg 2008; 34: 313-317.
49. Griffiths ER, Kaza AK, Wyler von Ballmoos MC, et al. Evaluating failing Fontans for heart transplantation: predictors of mortality. Ann Thorac Surg 2009; 88: 558-564.
50. Knott-Craig CJ, Danielson GK, Schaff HV, et al. The modified Fontan operation, J Thorac Cardiovasc Surg 1995; 109: 12371243.
51. Almond CSD, Mayer JE, Thiagarajan RR, et al. Outcome of Fontan failure and takedown to an intermediate palliative circulation. Ann Thorac Surg 2007; 84: 880-887.
52. Mitchell MB, Campbell DN, Ivy D, et al. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg 2004; 128: 693-702.
53. Jacobs JP, Quintessenza JA, Chai PJ, et al. Rescue cardiac transplantation for failing staged palliation in patients with hypoplastic heart syndrome. Cardiol Young 2006; 16: 556-562.
54. Soriano JR, Grima EZ, Vives MAA. Reversal of protein-losing enteropathy after heart transplantation in young patients. Rev Esp Cardiol 2009; 62: 937-40.
55. Brancaccio G, Carotti A, D'Argenio P, Michielon G, Parisi F. Protein-losing enteropathy after Fontan surgery: resolution after cardiac transplantation. J heart Lung Tranplant 2003; 22: 484-486